DOI QR코드

DOI QR Code

The Causes and Treatment Outcomes of 91 Patients with Adult Nosocomial Meningitis

  • Kim, Hye-In (Department of Internal Medicine, Kyungpook National University School of Medicine) ;
  • Kim, Shin-Woo (Department of Internal Medicine, Kyungpook National University School of Medicine) ;
  • Park, Ga-Young (Department of Internal Medicine, Kyungpook National University School of Medicine) ;
  • Kwon, Eu-Gene (Department of Internal Medicine, Kyungpook National University School of Medicine) ;
  • Kim, Hyo-Hoon (Department of Internal Medicine, Kyungpook National University School of Medicine) ;
  • Jeong, Ju-Young (Department of Internal Medicine, Kyungpook National University School of Medicine) ;
  • Chang, Hyun-Ha (Department of Internal Medicine, Kyungpook National University School of Medicine) ;
  • Lee, Jong-Myung (Department of Internal Medicine, Kyungpook National University School of Medicine) ;
  • Kim, Neung-Su (Department of Internal Medicine, Kyungpook National University School of Medicine)
  • Published : 2012.06.01

Abstract

Background/Aims: Frequent pathogens of nosocomial meningitis were investigated and the adequacy of empiric antibiotic therapy was assessed. Outcomes of nosocomial meningitis were also evaluated. Methods: Ninety-one patients, who were diagnosed and treated for nosocomial meningitis at a single tertiary hospital in Daegu, Korea for 10 years, were included. Medical record and electronic laboratory data on the causative pathogens, antibiotics used, and outcomes were retrospectively investigated. Results: Coagulase-negative Staphylococcus (40.9%) was the most common pathogen, followed by Acinetobacter (32.5%). Both were cultured as a single organism in cerebrospinal fluid (CSF). Seventy-eight patients (85.7%) had infections related to external ventricular drains (EVD). The most common empirical antibiotics were extended-spectrum beta-lactam antibiotics plus vancomycin (35/91, 38.6%). Of the 27 patients who had cultured Acinetobacter in CSF, 10 (37%) were given the wrong empirical antibiotic treatment. Seven of the 27 patients (26.9%) with cultured Acinetobacter died, and overall mortality of the 91 patients was 16.5%. In the multivariate analysis, the presence of combined septic shock (p < 0.001) and a persistent EVD state (p = 0.021) were associated with a poor prognosis. Conclusions: Acinetobacter is one of the leading pathogens of nosocomial meningitis and may lead to inadequate coverage of empiric antibiotic therapy due to increasing resistance. An EVD should be removed early in cases of suspected nosocomial meningitis, and carbapenem might be required for the poor treatment response.

Keywords

References

  1. van de Beek D, Drake JM, Tunkel AR. Nosocomial bacterial meningitis. N Engl J Med 2010;362:146-154. https://doi.org/10.1056/NEJMra0804573
  2. Streharova A, Benca J, Holeckova K, et al. Comparison of postsurgical and community acquired bacterial meningitis: analysis of 372 cases within a nationwide survey. Neuro Endocrinol Lett 2007;28 Suppl 3:7-9.
  3. Weisfelt M, van de Beek D, Spanjaard L, de Gans J. Nosocomial bacterial meningitis in adults: a prospective series of 50 cases. J Hosp Infect 2007;66:71-78. https://doi.org/10.1016/j.jhin.2007.02.017
  4. Ross D, Rosegay H, Pons V. Differentiation of aseptic and bacterial meningitis in postoperative neurosurgical patients. J Neurosurg 1988;69:669-674. https://doi.org/10.3171/jns.1988.69.5.0669
  5. Wang KW, Chang WN, Huang CR, et al. Post-neurosurgical nosocomial bacterial meningitis in adults: microbiology, clinical features, and outcomes. J Clin Neurosci 2005;12:647-650. https://doi.org/10.1016/j.jocn.2004.09.017
  6. Benca J, Ondrusova A, Kisac P, Krcmery V. Postoperative meningitis: shift in etiology? Neuro Endocrinol Lett 2007;28 Suppl 3:22.
  7. Pintado V, Meseguer MA, Fortun J, et al. Clinical study of 44 cases of Staphylococcus aureus meningitis. Eur J Clin Microbiol Infect Dis 2002;21:864-868.
  8. Hodges GR, Perkins RL. Hospital-associated bacterial meningitis. Am J Med Sci 1976;271:335-341. https://doi.org/10.1097/00000441-197605000-00009
  9. Tunkel AR, Hartman BJ, Kaplan SL, et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis 2004;39:1267-1284. https://doi.org/10.1086/425368
  10. Durand ML, Calderwood SB, Weber DJ, et al. Acute bacterial meningitis in adults: a review of 493 episodes. N Engl J Med 1993;328:21-28. https://doi.org/10.1056/NEJM199301073280104
  11. O'Neill E, Humphreys H, Phillips J, Smyth EG. Third-generation cephalosporin resistance among Gram-negative bacilli causing meningitis in neurosurgical patients: significant challenges in ensuring effective antibiotic therapy. J Antimicrob Chemother 2006;57:356-359. https://doi.org/10.1093/jac/dki462
  12. Erdem I, Hakan T, Ceran N, et al. Clinical features, laboratory data, management and the risk factors that affect the mortality in patients with postoperative meningitis. Neurol India 2008;56:433-437. https://doi.org/10.4103/0028-3886.44629
  13. Rodriguez Guardado A, Blanco A, Asensi V, et al. Multidrugresistant Acinetobacter meningitis in neurosurgical patients with intraventricular catheters: assessment of different treatments. J Antimicrob Chemother 2008;61:908-913. https://doi.org/10.1093/jac/dkn018
  14. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the cute care setting. Am J Infect Control 2008;36:309-332. https://doi.org/10.1016/j.ajic.2008.03.002
  15. Yoo JH. Infectious complications after neurosurgery: mainly focusing on ventriculitis and meningitis. Infect Chemother 2011;43:229-233. https://doi.org/10.3947/ic.2011.43.3.229
  16. Annane D, Bellissant E, Cavaillon JM. Septic shock. Lancet 2005;365:63-78. https://doi.org/10.1016/S0140-6736(04)17667-8
  17. Wen DY, Bottini AG, Hall WA, Haines SJ. Infections in neurologic surgery: the intraventricular use of antibiotics. Neurosurg Clin N Am 1992;3:343-354.
  18. Kim BN, Peleg AY, Lodise TP, et al. Management of meningitis due to antibiotic-resistant Acinetobacter species. Lancet Infect Dis 2009;9:245-255. https://doi.org/10.1016/S1473-3099(09)70055-6
  19. Beer R, Lackner P, Pfausler B, Schmutzhard E. Nosocomial ventriculitis and meningitis in neurocritical care patients. J Neurol 2008;255:1617-1624. https://doi.org/10.1007/s00415-008-0059-8
  20. Jarvis WR, Martone WJ. Predominant pathogens in hospital infections. J Antimicrob Chemother 1992;29 Suppl A:19-24. https://doi.org/10.1093/jac/29.suppl_A.19
  21. Vincent JL, Bihari DJ, Suter PM, et al. The prevalence of nosocomial infection in intensive care units in Europe: results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. JAMA 1995;274:639-644. https://doi.org/10.1001/jama.1995.03530080055041
  22. Gantz NM. Nosocomial central nervous system infections. In: Mayhall CG, ed. Hospital epidemiology and infection control. 2nd ed. Philadelphia: Lippincott Williams and Wilkins, 1999:301-322.
  23. Palabiyikoglu I, Tekeli E, Cokca F, et al. Nosocomial meningitis in a university hospital between 1993 and 2002. J Hosp Infect 2006;62:94-97. https://doi.org/10.1016/j.jhin.2005.06.010
  24. Katragkou A, Roilides E. Successful treatment of multidrugresistant Acinetobacter baumannii central nervous system infections with colistin. J Clin Microbiol 2005;43:4916-4917. https://doi.org/10.1128/JCM.43.9.4916-4917.2005
  25. Gales AC, Jones RN, Sader HS. Global assessment of the antimicrobial activity of polymyxin B against 54 731 clinical isolates of Gram-negative bacilli: report from the SENTRY antimicrobial surveillance programme (2001-2004). Clin Microbiol Infect 2006;12:315-321. https://doi.org/10.1111/j.1469-0691.2005.01351.x
  26. Falagas ME, Bliziotis IA, Tam VH. Intraventricular or intrathecal use of polymyxins in patients with Gram-negative meningitis: a systematic review of the available evidence. Int J Antimicrob Agents 2007;29:9-25. https://doi.org/10.1016/j.ijantimicag.2006.08.024

Cited by

  1. Nosocomial Meningitis: Moving beyond Description to Prevention vol.27, pp.2, 2012, https://doi.org/10.3904/kjim.2012.27.2.154
  2. Bacterial Meningitis in Older Adults vol.15, pp.4, 2012, https://doi.org/10.1007/s11940-013-0244-7
  3. An updated approach to healthcare-associated meningitis vol.12, pp.3, 2012, https://doi.org/10.1586/14787210.2014.890049
  4. Central Nervous System Device Infections vol.18, pp.11, 2012, https://doi.org/10.1007/s11908-016-0541-x
  5. Clinical Characteristics and Predictors of Adverse Outcome in Adult and Pediatric Patients With Healthcare-Associated Ventriculitis and Meningitis vol.3, pp.2, 2012, https://doi.org/10.1093/ofid/ofw077
  6. Hospital‐based study of the distribution of pathogens in adult bacterial meningitis with underlying disease in Tokyo, Japan vol.5, pp.1, 2012, https://doi.org/10.1111/ncn3.12087
  7. 2017 Infectious Diseases Society of America’s Clinical Practice Guidelines for Healthcare-Associated Ventriculitis and Meningitis* vol.64, pp.6, 2012, https://doi.org/10.1093/cid/ciw861
  8. Healthcare‐Associated Meningitis or Ventriculitis in Older Adults vol.65, pp.12, 2012, https://doi.org/10.1111/jgs.15099
  9. Successful treatment of multicompartmental cerebral ventriculitis caused by Acinetobacter baumanii vol.11, pp.None, 2012, https://doi.org/10.1016/j.idcr.2017.11.005
  10. The Organisms and Factors Affecting Outcomes of External Ventricular Drainage Catheter-Related Ventriculitis: A Penang Experience vol.13, pp.2, 2012, https://doi.org/10.4103/ajns.ajns_150_16
  11. Global etiology of bacterial meningitis: A systematic review and meta-analysis vol.13, pp.6, 2018, https://doi.org/10.1371/journal.pone.0198772
  12. Successful treatment of multidrug-resistant Acinetobacter baumannii meningitis with ampicillin sulbactam in primary hospital vol.32, pp.6, 2012, https://doi.org/10.1080/02688697.2017.1319907
  13. Bacterial external ventricular catheter-associated infection vol.18, pp.3, 2012, https://doi.org/10.1080/14787210.2020.1717949
  14. Clinical Features of Post-Operative Nosocomial Meningitis in Adults and Evaluation of Efficiency of Intrathecal Treatment vol.22, pp.10, 2012, https://doi.org/10.1089/sur.2021.024